Insight Medbotics today announced a successful 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the IGAR system, the company’s MRI-compatible robot.
Insight Medbotics Announces World’s First FDA-Cleared, MRI-Compatible Robot Read More »
Singleron has announced the launch of its AccuraCode® TCR library construction kit for high-throughput T-cell receptor profiling.
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote laboratory services.
Cada día, millones de personas en todo el mundo confían en el poder del jabón para mantener sus manos y cuerpos limpios. Pero ¿alguna vez te has preguntado por qué el jabón es tan efectivo para eliminar la suciedad y los gérmenes? La Qu&iacut …
En el vasto ámbito de las matemáticas, pocos teoremas han capturado la imaginación y la tenacidad de la comunidad matemática como el Teorema de Fermat. Conocido como el “último teorema de Fermat”, esta conjetura intrigó a los matemáticos dur …
El enigma resuelto: El Teorema de Fermat y su legado perdurable Read More »
Amphastar Pharmaceuticals, Inc. announced the pricing of $300.0 million aggregate principal amount of 2.00% convertible senior notes due 2029 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Recently, BioRay Pharmaceutical Co., Ltd. announced that its independently developed Class I innovative therapeutic biological product, Zuberitamab Injection, indicated for the treatment of CD20-positive diffuse large B-cell lymphoma, was officially approved for marketing by the National Medical Products Administration.
IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will participate at Pareto Securities’ 14th Annual Healthcare Conference on Thursday, September 14, 2023, in Stockholm, Sweden.
Rocket Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 7,812,500 shares of its common stock at a public offering price of $16.00 per share and to certain investors, pre-funded warrants to purchase 3,126,955 shares of common stock at a price of $15.99 per pre-funded warrant, which represents the per share public offering
Los desiertos, con su clima implacable y condiciones extremas, han sido durante mucho tiempo considerados lugares inhóspitos para la agricultura. Sin embargo, avances científicos y tecnológicos han abierto nuevas fronteras en la agricultura, permitiendo que terrenos árido …
Agricultura en el desierto: Innovación y sostenibilidad en tierras áridas Read More »
